Tarloxotinib is a hypoxia-activated pan-HER kinase inhibitor active against a broad range of HER-family oncogenes
| Image |  |
|---|---|
| Description | scientific article published on 22 December 2020 |
| Author/s |
author: Stephen V Liu Adam Patterson Chul Kim Jeff Smaill Shevan Silva Robert C Doebele Anh T Le |
| Publication date | December 22, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |